The Breast Cancer Index showed a weak negative correlation with ER and PR, and although the authors could not show statistical significance, the trend indicated more benefit from the endocrine treatment for decreasing ER mRNA as TAM was prolonged from 5 to 10 years. This evidence concerns the gene ESR1 and breast carcinoma.